HC Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals
HC Wainwright & Co. reiterated its Buy rating and $10.00 price target on Zentalis Pharmaceuticals. The target implies 369.5% upside from the Oct. 16 close of $2.13.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.